These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37208851)

  • 21. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population.
    Mostaghimi A; Gao W; Ray M; Bartolome L; Wang T; Carley C; Done N; Swallow E
    JAMA Dermatol; 2023 Apr; 159(4):411-418. PubMed ID: 36857069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demographic and Clinical Features of 1,641 Patients with Alopecia Areata, Alopecia Totalis, and Alopecia Universalis: A Single-Center Retrospective Study.
    Uzuncakmak TK; Engin B; Serdaroglu S; Tuzun Y
    Skin Appendage Disord; 2021 Jan; 7(1):8-12. PubMed ID: 33614711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topographic Phenotypes of Alopecia Areata and Development of a Prognostic Prediction Model and Grading System: A Cluster Analysis.
    Lee S; Kim BJ; Lee CH; Lee WS
    JAMA Dermatol; 2019 May; 155(5):564-571. PubMed ID: 30916724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis.
    Putterman E; Castelo-Soccio L
    J Am Acad Dermatol; 2018 Jun; 78(6):1207-1209.e1. PubMed ID: 29754888
    [No Abstract]   [Full Text] [Related]  

  • 25. Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis.
    Chanprapaph K; Pomsoong C; Kositkuljorn C; Suchonwanit P
    Drug Des Devel Ther; 2022; 16():107-116. PubMed ID: 35027820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis.
    Done N; Bartolome L; Swallow E; Gao W; Carley C; Wang T; Mostaghimi A
    Acta Derm Venereol; 2023 Aug; 103():adv12445. PubMed ID: 37622204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of the Risk of Alopecia Areata Progressing to Alopecia Totalis and Alopecia Universalis: Biomarker Development with Bioinformatics Analysis and Machine Learning.
    Zhang T; Nie Y
    Dermatology; 2022; 238(2):386-396. PubMed ID: 34004600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of tofacitinib in treatment of alopecia universalis in two patients.
    Gupta AK; Carviel JL; Abramovits W
    J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1373-8. PubMed ID: 27306107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.
    Liu LY; Craiglow BG; Dai F; King BA
    J Am Acad Dermatol; 2017 Jan; 76(1):22-28. PubMed ID: 27816293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil.
    Wang W; Gegentana ; Tonglaga ; Bagenna ; Li Y
    J Cosmet Dermatol; 2019 Aug; 18(4):1009-1013. PubMed ID: 31245963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical and intralesional therapies for alopecia areata.
    Alkhalifah A
    Dermatol Ther; 2011; 24(3):355-63. PubMed ID: 21689245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.
    Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C
    J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of treatment for alopecia totalis and alopecia universalis.
    Kassira S; Korta DZ; Chapman LW; Dann F
    Int J Dermatol; 2017 Aug; 56(8):801-810. PubMed ID: 28378336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of Methotrexate Combined with Low- to Moderate-Dose Corticosteroids for Severe Alopecia Areata.
    Anuset D; Perceau G; Bernard P; Reguiai Z
    Dermatology; 2016; 232(2):242-8. PubMed ID: 26735937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid.
    Puiu T; Reimer D; Sokumbi O
    J Drugs Dermatol; 2022 Aug; 21(8):894-895. PubMed ID: 35946979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five-year experience in the treatment of alopecia areata with DPC.
    El-Zawahry BM; Bassiouny DA; Khella A; Zaki NS
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):264-9. PubMed ID: 19744175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of psoralen-UV-A-Turban in alopecia areata.
    Broniarczyk-Dyla G; Wawrzycka-Kaflik A; Dubla-Berner M; Prusinska-Bratos M
    Skinmed; 2006; 5(2):64-8. PubMed ID: 16603835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe alopecia areata treated with systemic corticosteroids.
    Alabdulkareem AS; Abahussein AA; Okoro A
    Int J Dermatol; 1998 Aug; 37(8):622-4. PubMed ID: 9732014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hair growth with dupilumab in alopecia areata universalis and atopic dermatitis].
    Reinhold L; Lange K; Lindhof H; Homey B; Firouzi-Memarpuri P
    Dermatologie (Heidelb); 2022 Jul; 73(7):556-559. PubMed ID: 34609537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulse corticosteroid therapy for alopecia areata: long-term outcome after 10 years.
    Staumont-Sallé D; Vonarx M; Lengrand F; Segard M; Delaporte E
    Dermatology; 2012; 225(1):81-7. PubMed ID: 22964518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.